The FDA has updated its approval for 1-mg epinephrine nasal spray, removing the age limit to allow all patients weighing at least 33 lb to access the treatment.
Nicole Chase, MD
Advertisement
Nicole Chase, MD, is an allergist at St. Paul Allergy & Asthma.
Articles by Nicole Chase, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Recent advances in the treatment of molluscum contagiosum
2
FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older
3
New guideline updates care for central precocious puberty
4
Endocrine-disrupting chemicals detected in breast milk and infant urine through 6 months of age
5